Profilo
Erika Rich was the founder of Evogen, Inc. which was founded in 2001, where she held the title of Chief Administration Officer from 2001 to 2011.
Prior to that, she worked at AVAX Technologies, Inc. as a Principal from 1996 to 2001.
Precedenti posizioni note di Erika Rich
| Società | Posizione | Fine |
|---|---|---|
Evogen, Inc.
 Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics. Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation. | Fondatore | 10/08/2011 |
| AVAX TECHNOLOGIES, INC. | Corporate Officer/Principal | 01/01/2001 |
Esperienze
Posizioni ricoperte
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| AVAX TECHNOLOGIES, INC. | Health Technology |
| Aziende private | 1 |
|---|---|
Evogen, Inc.
Evogen, Inc. Electronic Equipment/InstrumentsElectronic Technology Evogen is a global biological detection system company, and is the leading developer and manufacturer of High Definition PCR™ (HD PCR) molecular diagnostics systems, meeting the needs of a diverse range of markets including biodefense, clinical, research, animal health, agbio, food and water safety, indoor air quality, environmental monitoring and forensics. Through its core expertise and patented technologies in the collection, concentration, preparation and detection of clinical and environmental biological samples, the company have developed product offerings that range from stand-alone modules and assay kits through to fully integrated units for dedicated diagnostic tasks. The company are developing both semi- and fully-automated rapid HD PCR diagnostic systems and Automated Sample Preparation (ASP) technology for sample preparation. | Electronic Technology |
- Borsa valori
- Insiders
- Erika Rich
